Login/Sign Up
MRP ₹561.5
(Inclusive of all Taxes)
₹84.2 Cashback (15%)
Aqurat-15 Tablet 4's is used to treat low sodium levels and autosomal dominant polycystic kidney disease. It contains Tolvaptan which works by increasing the amount of water released from the body via urine. In some cases, this medicine may cause side effects such as dizziness, headache, dry mouth, fatigue, diarrhoea, thirst and increased urge to urinate. Inform the doctor if you are pregnant or breastfeeding, taking any other medication, or have any pre-existing medical conditions.
Provide Delivery Location
About Aqurat-15 Tablet 4's
Aqurat-15 Tablet 4's is used to treat hyponatremia (low levels of sodium) in patients with heart failure, liver disease and hormonal imbalances such as Syndrome of Inappropriate Antidiuretic Hormone (SIADH). Additionally, Aqurat-15 Tablet 4's is also used to treat autosomal dominant polycystic kidney disease (ADPKD).
Aqurat-15 Tablet 4's contains ‘tolvaptan’ that works by blocking the effect of vasopressin, resulting in decreased water reabsorption, a net increase in free water excretion (aquaresis) and an increase in serum sodium concentrations.
In some cases, you may experience certain common side effects such as dizziness, headache, dry mouth, fatigue, diarrhoea, thirst and increased urge to urinate. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
You can take Aqurat-15 Tablet 4's with food or as advised by your doctor. It should be swallowed whole with a glass of water. Do not chew, bite, or break it. You are advised to take Aqurat-15 Tablet 4's as long as your doctor has prescribed it for you, depending on your medical condition.
Do not take Aqurat-15 Tablet 4's if you are allergic to it or any of its components. Avoid taking Aqurat-15 Tablet 4's if you are pregnant as it may cause foetal harm. Consult your doctor before taking Aqurat-15 Tablet 4's if you are breastfeeding. Aqurat-15 Tablet 4's is not recommended for children below 18 years as the efficacy and safety have not been established.
Uses of Aqurat-15 Tablet 4's
Aqurat-15 Tablet 4's used in the treatment of hyponatremia (low sodium levels) and autosomal dominant polycystic kidney disease (ADPKD). The detailed uses of Aqurat-15 Tablet 4's are as follows:
Have a query?
Directions for Use
Medicinal Benefits
How Aqurat-15 Tablet 4's Works
Storage
What if I have taken an overdose of Aqurat-15 Tablet 4's
Drug Warnings
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Unsafe
Avoid consuming alcohol while taking Aqurat-15 Tablet 4's as it may cause increased dizziness.
Pregnancy
Unsafe
Aqurat-15 Tablet 4's belongs to pregnancy category C. Aqurat-15 Tablet 4's is not recommended for use in pregnant women as it may cause foetal harm. Women of childbearing age must use effective contraception while taking Aqurat-15 Tablet 4's.
Breast Feeding
Unsafe
Aqurat-15 Tablet 4's is not recommended for use in breastfeeding women. Consult your doctor if you are breastfeeding; your doctor will decide whether Aqurat-15 Tablet 4's can be taken by breastfeeding mothers or not.
Driving
Caution
Aqurat-15 Tablet 4's may cause dizziness, weakness and tiredness. Do not drive or operate heavy machinery if you feel dizzy.
Liver
Caution
Aqurat-15 Tablet 4's should be used with caution in patients with liver impairment/liver disease. Please consult your doctor if you have liver problems or any concerns regarding this.
Kidney
Caution
Aqurat-15 Tablet 4's should be used with caution in patients with kidney disease. Please consult your doctor if you have kidney problems or any concerns regarding this.
Children
Unsafe
Aqurat-15 Tablet 4's is not recommended for children below 18 years as efficacy and safety have not been established.
Aqurat-15 Tablet 4's is used to treat hyponatremia (low levels of sodium) in patients with heart failure, liver disease and hormonal imbalances such as Syndrome of Inappropriate Antidiuretic Hormone (SIADH). Additionally, Aqurat-15 Tablet 4's is also used to treat autosomal dominant polycystic kidney disease (ADPKD).
Aqurat-15 Tablet 4's works by blocking the effect of vasopressin, a hormone which is involved in the formation of cysts in ADPKD patients. By blocking the effect of vasopressin, Aqurat-15 Tablet 4's slows down the development of cysts in the kidneys, reduces the symptoms of the disease, and increases urine production. Thereby increases serum sodium concentrations.
Dry mouth could be a side-effect of Aqurat-15 Tablet 4's. Limiting caffeine intake, avoiding smoking and mouthwashes containing alcohol, drinking water regularly and chewing sugar-free gum/candy might help in stimulating saliva and thereby prevents drying of the mouth.
Diarrhoea could be a side-effect of Aqurat-15 Tablet 4's. Drink plenty of fluid to prevent dehydration if you experience diarrhoea. Consult your doctor if you have severe diarrhoea or if you find blood in stools.
Aqurat-15 Tablet 4's may cause the liver to not work properly. Consult your doctor immediately if you experience nausea, vomiting, fever, loss of appetite, abdominal pain, tiredness, dark urine, jaundice, itching and flu-like symptoms.
Aqurat-15 Tablet 4's may cause water loss due to increased urine production. This might result in side-effects such as thirst, dry mouth and kidney problems. To prevent this, drink plenty of water regularly. Drink 1-2 glasses of water before going to bed even though you are not thirsty. Special care must be taken in patients with diseases that might reduce fluid intake.
Consult your doctor before taking Aqurat-15 Tablet 4's if you are diabetic as Aqurat-15 Tablet 4's might increase the blood sugar levels. Regular monitoring of blood glucose levels while taking Aqurat-15 Tablet 4's is advised.
You are advised to take Aqurat-15 Tablet 4's for the duration prescribed by the doctor. Aqurat-15 Tablet 4's should not be taken for more than 30 days.
Aqurat-15 Tablet 4's might increase the blood sugar levels. Consult the doctor if you are diabetic.
Do not take Aqurat-15 Tablet 4's if you are allergic to any of its components, if you have raised liver enzymes in the blood, very low blood volume, if there is no urine production, or if you cannot tell that you are thirsty.
Avoid consuming grapefruit or its juice while taking Aqurat-15 Tablet 4's as it might increase the effects of the medicine in the body.
Do not exceed the prescribed dose as it might cause an overdose. Taking an excess of Aqurat-15 Tablet 4's may cause excessive thirst, dizziness, excessive urination, or fainting. Consult the doctor if you experience these symptoms.
Aqurat-15 Tablet 4's is not recommended for patients with severe kidney disease. It should be used with caution in patients with mild to moderate kidney problems.
If you miss a dose of Aqurat-15 Tablet 4's take it as soon as you remember, However, if it is almost time for the scheduled dose, skip the missed dose and take the next dose at the scheduled time.
Aqurat-15 Tablet 4's is not recommended for use during pregnancy and breastfeeding.
Common side effects are dizziness, headache, dry mouth, fatigue, diarrhoea, thirst and increased urge to urinate. Talk to your doctor if you experience these side effects persistently.
Store Aqurat-15 Tablet 4's at room temperature, in a dry place. Keep out of sight and reach of children.
Treatment with Aqurat-15 Tablet 4's should be started and re-started in a hospital or in the presence of a healthcare professional to monitor the sodium levels in your blood closely. Too rapid correction of hyponatremia (low sodium levels) may cause osmotic demyelination syndrome (serious nerve damage). Consult the doctor if you notice symptoms of osmotic demyelination syndrome such as difficulty speaking, feeling that food or drinks are getting stuck in your throat, difficulty swallowing, mood changes, drowsiness, confusion, body movements that are difficult to control, weakness of the arms or legs, or seizures.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information